These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12184468)

  • 1. Asymptomatic hyperuricemia: to treat or not to treat.
    Dincer HE; Dincer AP; Levinson DJ
    Cleve Clin J Med; 2002 Aug; 69(8):594, 597, 600-2 passim. PubMed ID: 12184468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should we treat tophaceous gout in patients with allopurinol hypersensitivity?
    Grahame R; Simmonds HA; McBride MB; Marsh FP
    Adv Exp Med Biol; 1998; 431():19-23. PubMed ID: 9598024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
    [No Abstract]   [Full Text] [Related]  

  • 4. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 5. Urolithiasis in hyperuricemia and gout.
    Yu TF
    J Urol; 1981 Oct; 126(4):424-30. PubMed ID: 7288928
    [No Abstract]   [Full Text] [Related]  

  • 6. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late diagnosis of Lesch-Nyhan disease variant.
    Doucet BP; Jegatheesan D; Burke J
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24326440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels.
    Beutler AM; Rull M; Schlesinger N; Baker DG; Hoffman BI; Schumacher HR
    Clin Exp Rheumatol; 2001; 19(5):595. PubMed ID: 11579724
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperuricemia and gout.
    Sloan RW
    J Fam Pract; 1982 May; 14(5):923-6, 930-1, 934. PubMed ID: 7042900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urolithiasis in gout and hyperuricemic syndrome].
    Vachtenheim J; Srámek F
    Beitr Rheumatol; 1972; 18():56-60. PubMed ID: 4649119
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of decrease in hyperuricemia levels on joint, kidney and other symptoms in patients with gout].
    Kawenoki-Minc E
    Ter Arkh; 1987; 59(4):25-8. PubMed ID: 3589999
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperuricemia and gout: a reign of complacency.
    Mandell BF
    Cleve Clin J Med; 2002 Aug; 69(8):589-90, 592-3. PubMed ID: 12184467
    [No Abstract]   [Full Text] [Related]  

  • 13. Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.
    Cutolo M; Cimmino MA; Perez-Ruiz F
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4186-4195. PubMed ID: 29028079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of gout and urate calculi with allopurinol.
    O'Duffy JD; Scherbel AL
    Cleve Clin Q; 1968 Jul; 35(3):145-54. PubMed ID: 5757545
    [No Abstract]   [Full Text] [Related]  

  • 15. Febuxostat--treatment for hyperuricemia and gout?
    Moreland LW
    N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febuxostat efficacy in allopurinol-resistant tophaceous gout.
    Uh M; Reid G
    J Clin Rheumatol; 2011 Jun; 17(4):204-6. PubMed ID: 21617552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial gout and nephropathy in a young woman. Report of one case].
    Badilla A; Rojas C
    Rev Med Chil; 2001 Jun; 129(6):666-70. PubMed ID: 11510209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.